Cristobal Leal

GSBackers manages a venture capital portfolio of $250M+ and invests $1-10M+ checks on behalf of 2,000+ Stanford Graduate School of Business alumni (Class of ‘68 to Class of ‘27). We leverage two distinct features of the Stanford MBA community: (1) GSB founders have higher odds of building a unicorn than alums of any other business/graduate school in the world, and (2) GSB investors consistently outperform their peers and dominate the Forbes Midas List. By investing in and alongside Stanford alumni, we play with loaded dice and have unfair access to some of the best investment opportunities via our 2,000-member strong community that includes Partners at Sequoia, a16z, Founders Fund, NEA, Bessemer, Redpoint, Lightspeed, Khosla, etc. If youre a Stanford founder building a category-defining company or an alum looking for the best investment opportunities coming out of Stanford, send us a note! Select portfolio (in alphabetical order, by sector): 🇺🇸 Defense: Anduril ($60B) • Gecko ($1.25B) • Hermeus • Saronic ($9B) • Shield AI ($12B) • Skydio ($2.5B) • Ursa Major ($600M) • Vannevar Labs ($1.5B) 🛰️ Space: Apex Space Manufacturing ($1B+) • Loft ($1B) • Northwood • Varda Space Industries ✨ Artificial Intelligence & Infrastructure: Auradine • Axiom Math ($1.6B) • micro1 ($500M) • Pika ($470M) • Upscale AI ($1B) • You.com ($1.5B) 💰 Fintech: Deel ($17.3B) • Facio • Nala 🧬 Biotech & Healthcare: Genesis Therapeutics • Medra • Superpower • Synchron ⚡ Energy: Aalo ($1B+) • Exowatt ($1B+) • Realta Fusion

GSBackers manages a venture capital portfolio of $250M+ and invests $1-10M+ checks on behalf of 2,000+ Stanford Graduate School of Business alumni (Class of ‘68 to Class of ‘27). We leverage two distinct features of the Stanford MBA community: (1) GSB founders have higher odds of building a unicorn than alums of any other business/graduate school in the world, and (2) GSB investors consistently outperform their peers and dominate the Forbes Midas List. By investing in and alongside Stanford alumni, we play with loaded dice and have unfair access to some of the best investment opportunities via our 2,000-member strong community that includes Partners at Sequoia, a16z, Founders Fund, NEA, Bessemer, Redpoint, Lightspeed, Khosla, etc. If youre a Stanford founder building a category-defining company or an alum looking for the best investment opportunities coming out of Stanford, send us a note! Select portfolio (in alphabetical order, by sector): 🇺🇸 Defense: Anduril ($60B) • Gecko ($1.25B) • Hermeus • Saronic ($9B) • Shield AI ($12B) • Skydio ($2.5B) • Ursa Major ($600M) • Vannevar Labs ($1.5B) 🛰️ Space: Apex Space Manufacturing ($1B+) • Loft ($1B) • Northwood • Varda Space Industries ✨ Artificial Intelligence & Infrastructure: Auradine • Axiom Math ($1.6B) • micro1 ($500M) • Pika ($470M) • Upscale AI ($1B) • You.com ($1.5B) 💰 Fintech: Deel ($17.3B) • Facio • Nala 🧬 Biotech & Healthcare: Genesis Therapeutics • Medra • Superpower • Synchron ⚡ Energy: Aalo ($1B+) • Exowatt ($1B+) • Realta Fusion

Triage provides payment review, compliance, recovery and consulting services to hospitals. These reviews have recovered over $4.4+ billion -- and saved even more in future losses -- for some 800 hospital clients. Our client list includes the largest health systems in the country, university-affiliated centers, comprehensive cancer centers, childrens hospitals and small, stand-alone community hospitals. Triage audits HMO, PPO, Managed Medicare/caid, Medicaid, Medicare, Workers​ Compensation, and any other payer governed by a contract or fee schedule, in order to ensure that our clients receive full reimbursement. Three project objectives drive our review: 1. Identify and Recover Underpayments 2. Minimize Risk of Future Cash Loss 3. Provide Information for Future Contract Negotiations Our promise to our clients is that we will achieve maximum reimbursement with minimum disruption and zero up-front investment. Triage also provides litigation support, legal, capitation recovery services, contract analysis, and other A/R services.